Yüklüyor......
Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
Apixaban, an inhibitor of direct factor Xa, is used for the treatment of venous thromboembolic events or prevention of stroke. Unlike many other anticoagulant agents, it does not need periodic monitoring. However, monitoring is still required to determine the risk of bleeding due to overdose or surg...
Kaydedildi:
| Yayımlandı: | Transl Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Society for Clinical Pharmacology and Therapeutics
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6989270/ https://ncbi.nlm.nih.gov/pubmed/32055579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2019.27.1.33 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|